D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CLVS holding history
Clovis Oncology, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLVS overviewAll 13F holders of CLVSFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −44,924−100.0% | Sold out | Holders |
| Q3 2022 | 44,924 | $53.0K | <0.1% | +44,924 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −428,506−100.0% | Sold out | Holders |
| Q1 2022 | 428,506 | $866.0K | <0.1% | +64,120+17.6% | Added | Holders |
| Q4 2021 | 364,386 | $987.0K | <0.1% | +350,630+2,548.9% | Added | Holders |
| Q3 2021 | 13,756 | $61.0K | <0.1% | −8,487−38.2% | Reduced | Holders |
| Q2 2021 | 22,243 | $129.0K | <0.1% | −34,157−60.6% | Reduced | Holders |
| Q1 2021 | 56,400 | $396.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.